EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Overview of global real‐world data sources for pediatric pharmacoepidemiologic research

Gerold T Wharton iD, Claudia Becker, Dimitri Bennett iD, Mehmet Burcu iD, Greta Bushnell, Carmen Ferrajolo, Sigal Kaplan iD, Ann W McMahon iD, Naimisha Movva, Sudha R Raman, Oliver Scholle iD, Mina Suh und 2 weitere

Pharmacoepidemiology and Drug Safety · 2024-01 · 33 (1)

DOI: 10.1002/pds.5695 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmacoepidemiology and Drug Safety, online erschienen am 10.09.2023. Verfasst von Gerold T Wharton und 13 weiteren Autor:innen. Beteiligte Einrichtung: Office of Pediatric Therapeutics, US Food and Drug Administration, Silver Spring, Maryland, USA. Hauptthemen laut MEDLINE: Electronic Health Records, Pharmacoepidemiology. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, NCATS NIH HHS, NIAMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Given limited information available on real‐world data (RWD) sources with pediatric populations, this study describes features of globally available RWD sources for pediatric pharmacoepidemiologic research.

Methods

An online questionnaire about pediatric RWD sources and their attributes and capabilities was completed by members and affiliates of the International Society for Pharmacoepidemiology and representatives of nominated databases. All responses were verified by database representatives and summarized.

Results

Of 93 RWD sources identified, 55 unique pediatric RWD sources were verified, including data from Europe (47%), United States (38%), multiregion (7%), Asia‐Pacific (5%), and South America (2%). Most databases had nationwide coverage (82%), contained electronic health/medical records (47%) and/or administrative claims data (42%) and were linkable to other databases (65%). Most (71%) had limited outside access (e.g., by approval or through local collaborators); only 10 (18%) databases were publicly available. Six databases (11%) reported having >20 million pediatric observations. Most (91%) included children of all ages (birth until 18th birthday) and contained outpatient medication data (93%), while half (49%) contained inpatient medication data. Many databases captured vaccine information for children (71%), and one‐third had regularly updated data on pediatric height (31%) and weight (33%). Other pediatric data attributes captured include diagnoses and comorbidities (89%), lab results (58%), vital signs (55%), devices (55%), imaging results (42%), narrative patient histories (35%), and genetic/biomarker data (22%).

Conclusions

This study provides an overview with key details about diverse databases that allow researchers to identify fit‐for‐purpose RWD sources suitable for pediatric pharmacoepidemiologic research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Electronic Health RecordsPharmacoepidemiologyChildHumansAsiaInformation SourcesSurveys and QuestionnairesUnited States

Stichwörter der Autor:innen

global databasespediatric researchpharmacoepidemiologyreal-world data sourcesreal-world evidence

Autor:innen und Institutionen

  • Office of Pediatric Therapeutics, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy & Epidemiology, Department of Pharmaceutical Sciences, University Basel, Basel, Switzerland.
  • Global Evidence and Outcomes, Safety Pharmacoepidemiology, Takeda Development Center Americas, Inc., Cambridge, Massachusetts, USA.
  • Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Epidemiology, Merck & Co., Inc., Rahway, New Jersey, USA.
  • Department of Biostatistics and Epidemiology, Rutgers School of Public Health, New Brunswick, NJ, USA; Rutgers Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Re…

ORCID-Profile: Gerold T Wharton, Dimitri Bennett, Mehmet Burcu, Sigal Kaplan, Ann W McMahon, Oliver Scholle

Förderung

  • NICHD NIH HHS
  • NCATS NIH HHS
  • NIAMS NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Wharton, G. T., Becker, C., Bennett, D., Burcu, M., Bushnell, G., Ferrajolo, C., Kaplan, S., McMahon, A. W., Movva, N., Raman, S. R., Scholle, O., Suh, M., Sun, J. W., & Horton, D. B. (2024). Overview of global real‐world data sources for pediatric pharmacoepidemiologic research. Pharmacoepidemiology and Drug Safety, 33(1). https://doi.org/10.1002/pds.5695

Vancouver

Wharton GT, Becker C, Bennett D, Burcu M, Bushnell G, Ferrajolo C, et al. Overview of global real‐world data sources for pediatric pharmacoepidemiologic research. Pharmacoepidemiology and Drug Safety. 2024;33(1). doi:10.1002/pds.5695

BibTeX
@article{Wharton2024,
  author = {Wharton, Gerold T and Becker, Claudia and Bennett, Dimitri and Burcu, Mehmet and Bushnell, Greta and Ferrajolo, Carmen and Kaplan, Sigal and McMahon, Ann W and Movva, Naimisha and Raman, Sudha R and Scholle, Oliver and Suh, Mina and Sun, Jenny W and Horton, Daniel B},
  title = {Overview of global real‐world data sources for pediatric pharmacoepidemiologic research},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2024},
  volume = {33},
  number = {1},
  doi = {10.1002/pds.5695}
}
Kostenlos starten →